Abbvie (ABBV) P/S (2013 - 2026)
Abbvie (ABBV) P/S from Jan 2, 2013 to Jul 21, 2026. The TTM Abbvie (ABBV) P/S is 7.22. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Abbvie (ABBV)
| Year | P/S | Change |
|---|---|---|
| 2026 | 7.22 | +9.22% |
| 2025 | 6.61 | +18.44% |
| 2024 | 5.58 | +12.36% |
| 2023 | 4.97 | +0.33% |
| 2022 | 4.95 | +16.07% |
| 2021 | 4.26 | +3.05% |
| 2020 | 4.14 | +4.98% |
| 2019 | 3.94 | -7.32% |
| 2018 | 4.25 | -24.90% |
| 2017 | 5.66 | +39.87% |
| 2016 | 4.05 | -5.43% |
| 2015 | 4.28 | -18.13% |
| 2014 | 5.23 | +17.02% |
| 2013 | 4.47 | N/A |
Comparison Abbvie (ABBV) P/S with competitors
Abbvie (ABBV) P/S is 7.22.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -92.03% |
| NVO | Novo Nordisk | 0.66 | -90.83% |
| GRFS | Grifols SA | 0.67 | -90.70% |
| AMRN | Amarin Corp | 1.39 | -80.74% |
| SCLX | Scilex Holding Company | 1.92 | -73.47% |
| SNY | Sanofi | 2.18 | -69.76% |
| PFE | Pfizer Inc | 2.18 | -69.76% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -66.76% |
| BIIB | Biogen Inc | 2.93 | -59.41% |
| GSK | GSK Plc | 3.22 | -55.33% |
| MRK | Merck & Co Inc | 4.54 | -37.16% |
| AZN | Astrazeneca plc | 4.58 | -36.48% |
| NVS | Novartis AG | 5.07 | -29.76% |
| AMGN | AMGEN Inc | 5.15 | -28.65% |
| GILD | Gilead Sciences Inc | 5.43 | -24.77% |
| JNJ | Johnson & Johnson | 6.34 | -12.17% |
| LLY | Lilly(Eli) & Company | 14.28 | +97.83% |